研報掘金|華泰證券:維持舜宇光學“買入”評級 目標價80港元
華泰證券發佈研究報吿稱,維持對舜宇光學科技2023至2025年三年期間,各年淨利潤預測分別14.87億、21.39億及27.5億元,目標價80港元,相當於預測2024年市盈率36倍,維持“買入”評級。報吿指,手機攝像模組的非理性價格競爭,可能在下半年緩和,隨着蘋果銷售旺季開始,以及產能利用率的提升,舜宇光學科技手機攝像模組平均售價及毛利率將會復甦,持續關注舜宇的長期毛利率水平和復甦節奏。該行稱,舜宇車載鏡頭業務發展勢頭良好,上半年車載業務佔淨利潤超過50%,車載業務銷售額按年增長43.3%,成為舜宇最大的增長動力,相信公司可以保持全球第一的地位、強勁的增長勢頭、以及穩定的平均售價及毛利率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.